Archive for June, 2011

Individual Biotechnology Management Cases now Available

I am pleased to announce the availability of  individual cases from Building the Case for Biotechnology Management Case Studies in Science, Laws, Regulations, Politics, and Business in digital and printed formats. The casebook, which was recently reviewed in Nature Biotechnology, features 22 case studies in science; law, regulation, politics; and business, and a foreword by […]


Drug Patent Expirations in June 2011

Drug Patent Expirations in June 2011 *Drugs may be covered by multiple patents  Tradename Applicant Generic Name Patent Number Patent Expiration FEMARA Novartis Pharms letrozole 4,978,672 Jun 3, 2011 TAZORAC Allergan tazarotene 5,089,509 Jun 13, 2011 AVAGE Allergan tazarotene 5,089,509 Jun 13, 2011 NUEDEXTA Avanir Pharms dextromethorphan hydrobromide; quinidine sulfate 5,166,207 Jun 17, 2011 […]


Neglected Disease Drug Development: Incentives for Success

This paper is a final project from the NIH Foundation for Advanced Education in the Sciences TECH 366, a course in Biotechnology Management Neglected Disease Drug Development: Incentives for Success Dr. Jason Chong How are treatments being developed for neglected diseases? Historically, pharmaceutical research and development (R&D) of drugs have been driven by the private […]